Table 3

Univariate analyses of various clinicopathological parameters in relation to survival of patients with bladder cancer
Clinical features N OS PFS
3-year survival (%) P 3-year survival (%) P
Sex
Male 87 34 (39.1) 0.08 24 (27.6) 0.08
Female 39 22 (56.4) 18 (46.2)
Age (years)
≤70 55 20 (36.4) 0.1 13 (23.6) 0.1
>70 71 36 (50.7) 29 (40.8)
Stage
Ta 48 30 (62.5) 0.006 26 (54.2) 0.008
T1 46 22 (47.8) 12 (26.1)
≥T2 32 4 (12.5) 4 (12.5)
Grade
LMP 32 18 (56.2) 0.02 17 (53.1) 0.03
LG 43 21 (48.8) 15 (34.9)
HG 51 17 (33.3) 10 (19.6)
Carcinoma in situ
Yes 26 16 (61.5) 0.01 12 (46.2) 0.02
No 100 40 (40.0) 30 (30.0)
miR-100
High 48 33 (68.8) <0.001 26 (54.2) 0.001
Low 78 23 (29.5) 16 (20.5)

Wang et al.

Wang et al. Diagnostic Pathology 2012 7:159   doi:10.1186/1746-1596-7-159

Open Data